Detalhe da pesquisa
1.
Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma.
Am J Hematol
; 94(11): 1244-1253, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31456261
2.
Impaired B cell immunity in acute myeloid leukemia patients after chemotherapy.
J Transl Med
; 15(1): 155, 2017 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28693586
3.
Bone marrow biopsy in low-risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk group.
Am J Hematol
; 94(5): E146-E149, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30773670
4.
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function.
J Exp Med
; 203(12): 2691-702, 2006 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-17101732
5.
A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma.
Blood
; 116(18): 3554-63, 2010 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-20664052
6.
The potential benefits of participating in early-phase clinical trials in multiple myeloma: long-term remission in a patient with relapsed multiple myeloma treated with 90 cycles of lenalidomide and bortezomib.
Eur J Haematol
; 88(5): 446-9, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22300348
7.
A Focus on Relapsed Multiple Myeloma.
J Adv Pract Oncol
; 13(Suppl 4): 15-21, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35937465
8.
An Allogeneic Multiple Myeloma GM-CSF-Secreting Vaccine with Lenalidomide Induces Long-term Immunity and Durable Clinical Responses in Patients in Near Complete Remission.
Clin Cancer Res
; 27(24): 6696-6708, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34667029
9.
Cyclophosphamide, bortezomib, and dexamethasone combination in waldenstrom macroglobulinemia.
Am J Hematol
; 90(6): E122-3, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25703132
10.
Tailoring treatment for multiple myeloma patients with relapsed and refractory disease.
Oncology (Williston Park)
; 24(3 Suppl 2): 22-9, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20518367
11.
Oncology Nurse Practitioner Competencies: Defining Best Practices in the Oncology Setting.
Clin J Oncol Nurs
; 24(3): 296-304, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32441678
12.
Antiemetics: ASCO Guideline Update.
J Clin Oncol
; 38(24): 2782-2797, 2020 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32658626
13.
Activated Allogeneic Donor-derived Marrow-infiltrating Lymphocytes Display Measurable In Vitro Antitumor Activity.
J Immunother
; 42(3): 73-80, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30829726
14.
Oncology Nurse Practitioner Role: Recommendations From the Oncology Nursing Society's Nurse Practitioner Summit.
Clin J Oncol Nurs
; 22(5): 516-522, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30239518
15.
Bifunctional immune checkpoint-targeted antibody-ligand traps that simultaneously disable TGFß enhance the efficacy of cancer immunotherapy.
Nat Commun
; 9(1): 741, 2018 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29467463
16.
Introduction to B-Cell disorders.
Clin J Oncol Nurs
; 11(1 Suppl): 3-12, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17471822
17.
Activated marrow-infiltrating lymphocytes effectively target plasma cells and their clonogenic precursors.
Cancer Res
; 65(5): 2026-34, 2005 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15753403
18.
Immunomodulatory Agents and Proteasome Inhibitors in the Treatment of Multiple Myeloma.
Semin Oncol Nurs
; 33(3): 279-291, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28666621
19.
Heart and Lung Complications: Assessment and Prevention of Venous Thromboembolism and Cardiovascular Disease in Patients With Multiple Myelomaâ©.
Clin J Oncol Nurs
; 21(5 Suppl): 37-46, 2017 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28945734
20.
Bone Health, Pain, and Mobility: Evidence-Based Recommendations for Patients With Multiple Myeloma
Clin J Oncol Nurs
; 21(5 Suppl): 47-59, 2017 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28945729